{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T04:15:26Z","timestamp":1768796126282,"version":"3.49.0"},"reference-count":22,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2018,11,30]]},"DOI":"10.1536\/ihj.17-548","type":"journal-article","created":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T22:30:00Z","timestamp":1537828200000},"page":"1333-1339","source":"Crossref","is-referenced-by-count":12,"title":["Perioperative Sildenafil Therapy in Pediatric Congenital Cardiac Disease Patients"],"prefix":"10.1536","volume":"59","author":[{"given":"Li","family":"Jiang","sequence":"first","affiliation":[{"name":"Department of Pediatrics, The First Affiliated Hospital of Nanjing Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Zhang","sequence":"additional","affiliation":[{"name":"Pancreatic Center & Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangqing","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Rich JD, Rich S. Clinical diagnosis of pulmonary hypertension. Circulation 2014; 130: 1820-30.","DOI":"10.1161\/CIRCULATIONAHA.114.006971"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Gorenflo M, Gu H, Xu Z. Peri-operative pulmonary hypertension in paediatric patients: current strategies in children with congenital heart disease. Cardiology 2010; 116: 10-7.","DOI":"10.1159\/000313864"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Cheng XL, Liu ZH, Gu Q, <i>et al<\/i>. Prognostic value of pulmonary artery compliance in patients with pulmonary arterial hypertension associated with adult congenital heart disease. Int Heart J 2017; 58: 731-8.","DOI":"10.1536\/ihj.16-449"},{"key":"4","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1161\/01.CIR.87.2.440","volume":"87","year":"1993","unstructured":"4. Celermajer DS, Cullen S, Deanfield JE. Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics. Circulation 1993; 87: 440-6.","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kato K, Kato T, Hayano S, <i>et al<\/i>. Successful infant pneumonectomy with unilateral pulmonary artery occlusion test. Int Heart J 2018; 59: 237-9.","DOI":"10.1536\/ihj.16-606"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Bizzarro M, Gross I. Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease. Cochrane Database Syst Rev 2005; CD005055.","DOI":"10.1002\/14651858.CD005055.pub2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Bizzarro M, Gross I, Barbosa FT. Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease. Cochrane Database Syst Rev 2014; 7: CD005055.","DOI":"10.1002\/14651858.CD005055.pub3"},{"key":"8","unstructured":"8. Dodgen AL, Hill KD. Safety and tolerability considerations in the use of sildenafil for children with pulmonary arterial hypertension. Drug Healthc Patient Saf 2015; 7: 175-83."},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Barst RJ, Ivy DD, Gaitan G, <i>et al<\/i>. A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension. Circulation 2012; 125: 324-34.","DOI":"10.1161\/CIRCULATIONAHA.110.016667"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Barst RJ, Beghetti M, Pulido T, <i>et al<\/i>. STARTS-2: long-term survival with oral sildenafil monotherapy in treatment-naive pediatric pulmonary arterial hypertension. Circulation 2014; 129: 1914-23.","DOI":"10.1161\/CIRCULATIONAHA.113.005698"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Peiravian F, Amirghofran AA, Borzouee M, Ajami GH, Sabri MR, Kolaee S. Oral sildenafil to control pulmonary hypertension after congenital heart surgery. Asian Cardiovasc Thorac Ann 2007; 15: 113-7.","DOI":"10.1177\/021849230701500207"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Fraisse A, Butrous G, Taylor MB, Oakes M, Dilleen M, Wessel DL. Intravenous sildenafil for postoperative pulmonary hypertension in children with congenital heart disease. Intensive Care Med 2011; 37: 502-9.","DOI":"10.1007\/s00134-010-2065-4"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. El Midany AA, Mostafa EA, Azab S, Hassan GA. Perioperative sildenafil therapy for pulmonary hypertension in infants undergoing congenital cardiac defect closure. Interact Cardiovasc Thorac Surg 2013; 17: 963-8.","DOI":"10.1093\/icvts\/ivt353"},{"key":"14","unstructured":"14. Peiravian F, Amirghofran AA, Ghamsari H, Emaminia A. Additive effect of phosphodiesterase inhibitors in control of pulmonary hypertension after congenital cardiac surgery in children. Iran J Pediatr 2013; 23: 19-26."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sharma VK, Joshi S, Joshi A, Kumar G, Arora H, Garg A. Does intravenous sildenafil clinically ameliorate pulmonary hypertension during perioperative management of congenital heart diseases in children? - A prospective randomized study. Ann Card Anaesth 2015; 18: 510-6.","DOI":"10.4103\/0971-9784.166457"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Samiee-Zafarghandy S, Smith PB, van den Anker JN. Safety of sildenafil in infants*. Pediatr Crit Care Med 2014; 15: 362-8.","DOI":"10.1097\/PCC.0000000000000077"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Lobato EB, Beaver T, Muehlschlegel J, Kirby DS, Klodell C, Sidi A. Treatment with phosphodiesterase inhibitors type III and V: milrinone and sildenafil is an effective combination during thromboxane-induced acute pulmonary hypertension. Br J Anaesth 2006; 96: 317-22.","DOI":"10.1093\/bja\/ael009"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Badesch DB, Champion HC, Sanchez MA, <i>et al<\/i>. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54: S55-66.","DOI":"10.1016\/j.jacc.2009.04.011"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Yang Y, Feng Y, Zhou XG, Pan JJ, Zhou XY. Inhaled nitric oxide in preterm infants: An updated meta-analysis. J Res Med Sci 2016; 21: 41.","DOI":"10.4103\/1735-1995.183990"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Igarashi A, Inoue S, Ishii T, Tsutani K, Watanabe H. Comparative effectiveness of oral medications for pulmonary arterial hypertension. Int Heart J 2016; 57: 466-72.","DOI":"10.1536\/ihj.15-459"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Roldan T, Deiros L, Romero JA, Gutierrez-Larraya F, Herrero A, Del Cerro MJ. Safety and tolerability of targeted therapies for pulmonary hypertension in children. Pediatr Cardiol 2014; 35: 490-8.","DOI":"10.1007\/s00246-013-0811-4"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Simonca L, Tulloh R. Sildenafil in infants and children. Children (Basel) 2017; 4: 60.","DOI":"10.3390\/children4070060"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/59\/6\/59_17-548\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T16:42:53Z","timestamp":1662136973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/59\/6\/59_17-548\/_article"}},"subtitle":["A Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2018,11,30]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.17-548","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,30]]}}}